Ionis Pharmaceuticals Inc (IONS)
42.45
+0.61
(+1.46%)
USD |
NASDAQ |
Apr 24, 16:00
42.46
+0.01
(+0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Total Liabilities (Quarterly): 2.603B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.603B |
| September 30, 2023 | 2.619B |
| June 30, 2023 | 2.543B |
| March 31, 2023 | 2.399B |
| December 31, 2022 | 1.961B |
| September 30, 2022 | 1.828B |
| June 30, 2022 | 1.831B |
| March 31, 2022 | 1.810B |
| December 31, 2021 | 1.840B |
| September 30, 2021 | 1.884B |
| June 30, 2021 | 1.914B |
| March 31, 2021 | 1.568B |
| December 31, 2020 | 1.646B |
| September 30, 2020 | 1.489B |
| June 30, 2020 | 1.484B |
| March 31, 2020 | 1.521B |
| December 31, 2019 | 1.549B |
| September 30, 2019 | 1.397B |
| June 30, 2019 | 1.421B |
| March 31, 2019 | 1.448B |
| December 31, 2018 | 1.481B |
| September 30, 2018 | 1.408B |
| June 30, 2018 | 1.430B |
| March 31, 2018 | 912.46M |
| December 31, 2017 | 957.49M |
| Date | Value |
|---|---|
| September 30, 2017 | 854.89M |
| June 30, 2017 | 875.26M |
| March 31, 2017 | 882.19M |
| December 31, 2016 | 812.90M |
| September 30, 2016 | 703.95M |
| June 30, 2016 | 699.90M |
| March 31, 2016 | 717.66M |
| December 31, 2015 | 747.11M |
| September 30, 2015 | 742.59M |
| June 30, 2015 | 675.94M |
| March 31, 2015 | 679.58M |
| December 31, 2014 | 698.03M |
| September 30, 2014 | 449.03M |
| June 30, 2014 | 450.92M |
| March 31, 2014 | 460.51M |
| December 31, 2013 | 468.77M |
| September 30, 2013 | 480.47M |
| June 30, 2013 | 387.57M |
| March 31, 2013 | 351.87M |
| December 31, 2012 | 362.92M |
| September 30, 2012 | 315.40M |
| June 30, 2012 | 318.08M |
| March 31, 2012 | 319.94M |
| December 31, 2011 | 313.46M |
| September 30, 2011 | 318.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.397B
Minimum
Sep 2019
2.619B
Maximum
Sep 2023
1.858B
Average
1.828B
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 235.21M |
| Viking Therapeutics Inc | 20.07M |
| Alnylam Pharmaceuticals Inc | 4.051B |
| Akero Therapeutics Inc | 44.96M |
| 89bio Inc | 59.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.990B |
| Shareholders Equity (Quarterly) | 386.69M |
| Debt to Equity Ratio | 3.317 |
| Current Ratio | 5.896 |
| Net Debt Paydown Yield | -0.16% |